Dublin, July 22, 2025 (GLOBE NEWSWIRE) — The “Japan In Vitro Diagnostics Market Report and Forecast 2025-2034” has been added to ResearchAndMarkets.com’s offering.
The Japan in vitro diagnostics market, valued at USD 3.97 Billion in 2024, is poised for significant growth driven by an aging population and increasing demand for personalized medicine. Expected to grow at a CAGR of 6.20% from 2025 to 2034, the market is projected to reach USD 7.24 Billion by 2034. The presence of advanced healthcare infrastructure and the adoption of molecular diagnostics are key factors fueling this growth. Emerging trends such as AI-integrated testing and home-based diagnostics are anticipated to further accelerate market expansion during the forecast period.
Market Overview The in vitro diagnostics (IVD) market in Japan is propelled by factors such as an aging population, rising chronic disease burden, and technological advancements. Demand for point-of-care testing and government support are crucial contributors to market growth. The market is estimated to grow at a CAGR of 6.20% between 2025 and 2034.
Growth Drivers Advanced diagnostic tools targeting antimicrobial resistance play a significant role in market growth. In July 2024, Shionogi & Co., Ltd launched the “Shionogi MIC Dry Plate Cefiderocol” to evaluate bacterial susceptibility to Fetroja, enhancing targeted antibiotic use and reinforcing the nation’s disease diagnostics framework. Innovations like these are expected to propel the market forward.
Market Trends The industry is witnessing an array of trends including regulatory approvals for novel cancer diagnostics alongside a boost in innovation and strategic collaborations. Regulatory advancements bolster the market’s potential, boosting clinical outcomes through novel cancer diagnostics.
Innovation in Cancer Diagnostics Regulatory approvals are driving innovation. In June 2023, Toray Industries’ “Toray APOA2-iTQ” received approval from Japan’s Ministry of Health, Labour and Welfare, marking a milestone in in vitro diagnostic tools for pancreatic cancer, thus enhancing clinical outcomes and bolstering market growth.
Strategic Collaborations In August 2024, a partnership between Hitachi High-Tech and Gencurix focuses on developing advanced cancer molecular diagnostic testing services. This collaboration aims to improve biomarker-based diagnostics in oncology, aligning with the increasing demand for precise diagnostics.
Market Segmentation
By Product & Services: Reagents and Kits, Instruments, Software and ServicesBy Technology: Immunodiagnostics, ELISA, ELISPOT, Rapid Tests, RIA, Western Blotting, OthersBy Application: Infectious Diseases, Diabetes, Oncology, Cardiology, Drug TestingBy End User: Hospitals, Diagnostic Centers, Point-of-Care Testing, Academic Institutes
Market Share Among various applications, infectious diseases dominate the market due to significant public health impact. In 2021, Japan reported 11,519 new tuberculosis cases, with government initiatives supporting this market segment’s growth.
Leading Players Key players include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, bioMerieux SA, and Abbott, each contributing through advanced diagnostic solutions and strategic business initiatives. Other notable companies include Sysmex Corporation, Thermo Fisher Scientific Inc., and QIAGEN.
Key Questions Answered
What are the market’s forecast outlook and major drivers?Which products and services are expected to dominate the market?What are the major current trends?Who are the key players in the market?What challenges and opportunities exist?
Key Attributes:
Report AttributeDetailsNo. of Pages250Forecast Period2025 – 2034Estimated Market Value (USD) in 2025$3.97 Billion Forecasted Market Value (USD) by 2034$7.24 Billion Compound Annual Growth Rate6.2%Regions CoveredJapan
Key Topics Covered:
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 In Vitro Diagnostics Market Overview
3.1 Asia Pacific In Vitro Diagnostics Market Overview
3.2 Japan In Vitro Diagnostics Market Overview
4 Japan In Vitro Diagnostics Market Landscape
4.1 Japan In Vitro Diagnostics Market: Developers Landscape
4.2 Japan In Vitro Diagnostics Market: Product Landscape
5 Japan In Vitro Diagnostics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 PESTEL Analysis
5.4 Porter’s Five Forces Model
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Japan In Vitro Diagnostics Market Segmentation (2018-2034)
6.1 Japan In Vitro Diagnostics Market by Product & Services
6.2 Japan In Vitro Diagnostics Market by Technology
6.3 Japan In Vitro Diagnostics Market by Application
6.4 Japan In Vitro Diagnostics Market by End User
7 Regulatory Framework
8 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
9 Strategic Initiatives
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Initiative
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Supplier Landscape
10.1 Market Share Analysis (Top 5 Companies)
10.2 F. Hoffmann-La Roche Ltd.
10.3 Bio-Rad Laboratories, Inc.
10.4 bioMerieux SA
10.5 Sysmex Corporation
10.6 Abbott
10.7 Thermo Fisher Scientific Inc.
10.8 QIAGEN
10.9 Quidel Corporation
10.10 Danaher Corporation
11 Japan In Vitro Diagnostics Market – Distribution Model (Additional Insight)
12 Key Opinion Leaders (KOL) Insights (Additional Insight)
Companies Featured
F. Hoffmann-La Roche Ltd.Bio-Rad Laboratories, Inc.bioMerieux SAAbbott
For more information about this report visit https://www.researchandmarkets.com/r/c9s08d
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Japanese In Vitro Diagnostics Market
AloJapan.com